ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

Nowakowski, GS; Chiappella, A; Gascoyne, RD; Scott, DW; Zhang, QY; Jurczak, W; Ozcan, M; Hong, XN; Zhu, J; Jin, J; Belada, D; Bergua, JM; Piazza, F; Mocikova, H; Molinari, AL; Yoon, DH; Cavallo, F; Tani, M; Yamamoto, K; Izutsu, K; Kato, K; Czuczman, M; Hersey, S; Kilcoyne, A; Russo, J; Hudak, K; Zhang, JS; Wade, S; Witzig, TE; Vitolo, U

Nowakowski, GS (corresponding author), Mayo Clin, Div Hematol, 201 First St SW, Rochester, MN 55902 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (12): 1317

Abstract

PURPOSEPatients with the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) historically showed inferior survival with stand......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索